INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION AND SYNCYTIUM FORMATION IN HUMAN-CELLS BY V3 LOOP SYNTHETIC PEPTIDES FROM GP120

被引:39
|
作者
NEHETE, PN [1 ]
ARLINGHAUS, RB [1 ]
SASTRY, KJ [1 ]
机构
[1] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT MOLEC PATHOL,HOUSTON,TX 77030
关键词
D O I
10.1128/JVI.67.11.6841-6846.1993
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Because V3 loop-specific antibodies have been shown to inhibit human immunodeficiency virus type 1 (HIV-1) infection of human cells and because specific mutations in the V3 loop render the virus ineffective for infection and syncytium formation, we tested the anti-HIV effects of V3 loop peptides from different HIV-1 strains. We obtained evidence that V3 loop synthetic peptides of 8 to 15 amino acids at nanogram concentrations efficiently blocked HIV-1 IIIB infection of several human T-cell lines and of freshly prepared normal human T cells. More importantly, syncytium formation by three different primary clinical HIV isolates was inhibited by the V3 loop peptide from HIV-1 IIIB at a concentration Of 1 mug/ml. Concentrations of V3 peptides up to 50 mug/ml were not toxic to any of the human cells studied. Additionally, V3 peptides incubated in normal human serum or plasma exhibited biological and physical stability for up to 24 h. Taken together, these results suggest that the V3 loop peptides have medical utility as therapeutic reagents to either prevent HIV-1 infection in humans or reduce the spread of virus infection in HIV-infected individuals. These findings are especially significant because a number of reports in the literature indicate that the V3 loop region in gp120 Plays an important role in the initial stages of HIV-1 infection of cells.
引用
收藏
页码:6841 / 6846
页数:6
相关论文
共 50 条
  • [1] MOLECULAR MIMICRY BETWEEN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 V3 LOOP AND HUMAN BRAIN PROTEINS
    TRUJILLO, JR
    MCLANE, MF
    LEE, TH
    ESSEX, M
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (12) : 7711 - 7715
  • [2] AN N-GLYCAN WITHIN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 V3 LOOP AFFECTS VIRUS NEUTRALIZATION
    BACK, NKT
    SMIT, L
    DEJONG, JJ
    KEULEN, W
    SCHUTTEN, M
    GOUDSMIT, J
    TERSMETTE, M
    [J]. VIROLOGY, 1994, 199 (02) : 431 - 438
  • [3] Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop
    Stanfield, RL
    Ghiara, JB
    Saphire, EO
    Profy, AT
    Wilson, IA
    [J]. VIROLOGY, 2003, 315 (01) : 159 - 173
  • [4] Conformational model for the human immunodeficiency virus type 1 gp120 V3 loop
    不详
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2005, 22 (06): : 779 - 779
  • [5] MOLECULAR DETERMINANTS OF THE V3 LOOP OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GLYCOPROTEIN GP120 RESPONSIBLE FOR CONTROLLING CELL TROPISM
    CHAVDA, SC
    GRIFFIN, P
    ZHEN, HL
    KEYS, B
    VEKONY, MA
    CANN, AJ
    [J]. JOURNAL OF GENERAL VIROLOGY, 1994, 75 : 3249 - 3253
  • [6] Activation of gp120 of human immunodeficiency virus by their V3 loop-derived peptides
    Ling, H
    Zhang, XY
    Usami, O
    Hattori, T
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 297 (03) : 625 - 631
  • [7] ENHANCEMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION BY ANTISERA TO PEPTIDES FROM THE ENVELOPE GLYCOPROTEINS GP120/GP41
    JIANG, S
    LIN, K
    NEURATH, AR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (06): : 1557 - 1563
  • [8] A BROADLY NEUTRALIZING MONOCLONAL-ANTIBODY THAT RECOGNIZES THE V3 REGION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GLYCOPROTEIN GP120
    OHNO, T
    TERADA, M
    YONEDA, Y
    SHEA, KW
    CHAMBERS, RF
    STROKA, DM
    NAKAMURA, M
    KUFE, DW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) : 10726 - 10729
  • [9] CONSERVED V3 LOOP SEQUENCES AND TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    SHPAER, EG
    DELWART, EL
    KUIKEN, CL
    GOUDSMIT, J
    BACHMANN, MH
    MULLINS, JI
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (12) : 1679 - 1684
  • [10] BINDING OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-I (HIV-1) GP120 TO GALACTOSYLCERAMIDE (GALCER) - RELATIONSHIP TO THE V3 LOOP
    COOK, DG
    FANTINI, J
    SPITALNIK, SL
    GONZALEZSCARANO, F
    [J]. VIROLOGY, 1994, 201 (02) : 206 - 214